These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 36535924)

  • 21. Comparison of Survival Rates After a Combination of Local Treatment and Systemic Therapy vs Systemic Therapy Alone for Treatment of Stage IV Non-Small Cell Lung Cancer.
    Uhlig J; Case MD; Blasberg JD; Boffa DJ; Chiang A; Gettinger SN; Kim HS
    JAMA Netw Open; 2019 Aug; 2(8):e199702. PubMed ID: 31433481
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surgery versus stereotactic body radiotherapy for clinical stage I non-small-cell lung cancer: propensity score-matching analysis including the ratio of ground glass nodules.
    Tomita N; Okuda K; Osaga S; Miyakawa A; Nakanishi R; Shibamoto Y
    Clin Transl Oncol; 2021 Mar; 23(3):638-647. PubMed ID: 32705493
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical efficacy of thermal ablation for the treatment of pulmonary carcinoid tumor: a propensity-matched analysis.
    Yang H; Li M; Liu T; Luo L
    Int J Hyperthermia; 2023; 40(1):2225817. PubMed ID: 37364893
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An economic analysis of sublobar resection versus thermal ablation for early-stage non-small-cell lung cancer.
    Kwan SW; Mortell KE; Hippe DS; Brunner MC
    J Vasc Interv Radiol; 2014 Oct; 25(10):1558-64; quiz 1565. PubMed ID: 25130308
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of surgery on survival in patients with stage III N2 small cell lung cancer: propensity score matching analysis and nomogram development and validation.
    Chai Y; Ma Y; Feng W; Lu H; Jin L
    World J Surg Oncol; 2021 Aug; 19(1):258. PubMed ID: 34461929
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intensity-Modulated Radiation Therapy May Improve Local-Regional Tumor Control for Locally Advanced Non-Small Cell Lung Cancer Compared With Three-Dimensional Conformal Radiation Therapy.
    Wang J; Zhou Z; Liang J; Feng Q; Xiao Z; Hui Z; Wang X; Lv J; Chen D; Zhang H; Ji Z; Cao J; Liu L; Jiang W; Men Y; Xu C; Dai J; Yin W; Wang L
    Oncologist; 2016 Dec; 21(12):1530-1537. PubMed ID: 27628491
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microwave Ablation Versus Wedge Resection for Stage I Non-small Cell Lung Cancer Adjacent to the Pericardium: Propensity Score Analyses of Long-term Outcomes.
    Hu H; Zhai B; Liu R; Chi JC
    Cardiovasc Intervent Radiol; 2021 Feb; 44(2):237-246. PubMed ID: 32909064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness of Thermal Ablation and Stereotactic Radiotherapy Based on Stage I Lung Cancer Histology.
    Uhlig J; Mehta S; Case MD; Dhanasopon A; Blasberg J; Homer RJ; Solomon SB; Kim HS
    J Vasc Interv Radiol; 2021 Jul; 32(7):1022-1028.e4. PubMed ID: 33811997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcomes of local thoracic surgery in patients with stage IV non-small-cell lung cancer: A SEER-based analysis.
    Jia J; Guo B; Yang Z; Liu Y; Ga L; Xing G; Zhang S; Jin A; Ma R; Wang J
    Eur J Cancer; 2021 Feb; 144():326-340. PubMed ID: 33388490
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gustave Roussy Immune Score based on a three-category risk assessment scale serves as a novel and effective prognostic indicator for surgically resectable early-stage non-small-cell lung cancer: A propensity score matching retrospective cohort study.
    Li SJ; Zhao L; Wang HY; Zhou HN; Ju J; Du H; Che GW
    Int J Surg; 2020 Dec; 84():25-40. PubMed ID: 33086147
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the outcomes of stereotactic body radiotherapy versus surgical treatment for elderly (≥70) patients with early-stage non-small cell lung cancer after propensity score matching.
    Dong B; Wang J; Zhu X; Chen Y; Xu Y; Shao K; Zheng L; Ying H; Chen M; Cao J
    Radiat Oncol; 2019 Nov; 14(1):195. PubMed ID: 31699115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemotherapy for advanced pulmonary sarcomatoid carcinoma: a population-based propensity score matching study.
    Wang F; Yu X; Han Y; Gong C; Yan D; Yang L; Li J; Liu S
    BMC Pulm Med; 2023 Jul; 23(1):262. PubMed ID: 37454075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcome of Non-small Cell Lung Cancer Patients With N3 Stage: Survival Analysis of Propensity Score Matching With a Validated Predictive Nomogram.
    Han C; Wu Y; Sun X; Chong Y; Kang K; Liu Z; Zhang F
    Front Surg; 2021; 8():666332. PubMed ID: 33996887
    [No Abstract]   [Full Text] [Related]  

  • 34. Choice of Treatment for Stage IA Non-small Cell Lung Cancer Patients Ineligible for Surgery: Ablation or Stereotactic Body Radiotherapy?
    Liang L; Li G; Xie S; Sun G; Zhang M; Sun F; Peng A
    J Cancer; 2020; 11(6):1634-1640. PubMed ID: 32047569
    [No Abstract]   [Full Text] [Related]  

  • 35. Association between number of dissected lymph nodes and survival in stage IA non-small cell lung cancer: a propensity score matching analysis.
    Wu LL; Lai JJ; Liu X; Huang YY; Lin P; Long H; Zhang LJ; Ma GW
    World J Surg Oncol; 2020 Dec; 18(1):322. PubMed ID: 33287841
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The benefit of radiotherapy in distant metastatic small-cell lung cancer: A retrospective study based on propensity score matching (PSM).
    Qie S; Shi H; Wang F; Liu F; Zhang X; Sun X
    Medicine (Baltimore); 2022 Sep; 101(36):e30510. PubMed ID: 36086681
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Efficacy analysis of radiotherapy combined with surgery for locally advanced rectal mucinous adenocarcinoma: a retrospective study based on data of Surveillance, Epidemiology, and End results population].
    Zhang Y; Wang X; Chi P; Lin H; Lu X; Huang Y; Xu Z; Huang S; Sun Y; Ye D
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):85-93. PubMed ID: 30703799
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of long-term survival outcomes between stereotactic body radiotherapy and sublobar resection for stage I non-small-cell lung cancer in patients at high risk for lobectomy: A propensity score matching analysis.
    Matsuo Y; Chen F; Hamaji M; Kawaguchi A; Ueki N; Nagata Y; Sonobe M; Morita S; Date H; Hiraoka M
    Eur J Cancer; 2014 Nov; 50(17):2932-8. PubMed ID: 25281527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lobectomy, sublobar resection, and stereotactic ablative radiotherapy for early-stage non-small cell lung cancers in the elderly.
    Shirvani SM; Jiang J; Chang JY; Welsh J; Likhacheva A; Buchholz TA; Swisher SG; Smith BD
    JAMA Surg; 2014 Dec; 149(12):1244-53. PubMed ID: 25321323
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcomes for Surgery in Stage IA Large Cell Lung Neuroendocrine Compared With Other Types of Non-Small Cell Lung Cancer: A Propensity Score Matching Study Based on the Surveillance, Epidemiology, and End Results (SEER) Database.
    Zou L; Guo T; Ye L; Zhou Y; Chu L; Chu X; Ni J; Zhu Z; Yang X
    Front Oncol; 2020; 10():572462. PubMed ID: 33324549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.